Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
43 hedge funds and large institutions have $14.2M invested in Enzo Biochem, Inc. in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
10% more funds holding
Funds holding: 39 → 43 (+4)
5% more capital invested
Capital invested by funds: $13.5M → $14.2M (+$676K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BP
BBR Partners
New York
|
+$112K |
| 2 |
Squarepoint
New York
|
+$63.4K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$54.5K |
| 4 |
Renaissance Technologies
New York
|
+$31.3K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$29.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$40.1K |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$21.6K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.07K |
| 4 |
SCA
Snowden Capital Advisors
New York
|
-$2.01K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$498 |
ENZ Hedge Fund Activity: Q3 2024 in Review
43 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q3 2024, worth a combined $14.2M — up 5% from $13.5M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ENZ positions and 2 closed out — a net gain of 4 holders — while 8 added to existing stakes and 6 trimmed.
The largest buyer was BBR Partners, opening a new position worth an estimated $112K. The largest seller was Dimensional Fund Advisors, cutting an estimated $40.1K.
- 43 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q3 2024, up from 39 in Q2 2024.
- Funds reported $14.2M of Enzo Biochem, Inc. stock for Q3 2024, up 5% quarter-over-quarter.
- 6 funds opened new Enzo Biochem, Inc. positions in Q3 2024 and 2 closed out, a net change of +4 holders.
- The largest Enzo Biochem, Inc. buyer in Q3 2024 was BBR Partners, an estimated $112K added.
- The largest Enzo Biochem, Inc. seller in Q3 2024 was Dimensional Fund Advisors, an estimated $40.1K sold.
Based on aggregated 13F filings for Q3 2024.